Your Account
Sort
Categories
- #EMSPVirtual2021
- Associate members
- Document
- EMSP Events
- EMSP Events|EMSP News
- EMSP News
- EMSP News|From Europe
- EMSP News|From Europe|Stakeholder Events
- EMSP News|MS Research
- EMSP News|Press Releases
- EMSP News|Young People with MS
- From Europe
- From Europe|Member News
- From Europe|Stakeholder Events
- From Europe|Young People with MS
- Full members
- Full members|Member News
- Member News
- Member News|Young People with MS
- MS Research
- News – EMSP
- Press Releases
- Stakeholder Events
- Uncategorized
- Young People with MS
Portugal: Newly diagnosed MS athlete becomes bodysurf champion
The Portuguese MS Society (SPEM) announced that recently diagnosed bodysurfer and runner Miguel Rocha (pictured below) won the National Bodysurf…
EMSP launches Membership Newsletter
We are glad to announce the launch of our Membership Newsletter, available as of 17 October 2016. The newsletter is a collaborative initiative made possible with the great support of MS societies across Europe.
World Mental Health Day: Young people in the digital age
EMSP’s partners at Mental Health Europe joined by healthcare stakeholders and policymakers marked World Mental Health Day 2016 with a…
World Mental Health Day: Young people in the digital age
EMSP’s partners at Mental Health Europe joined by healthcare stakeholders and policymakers marked World Mental Health Day 2016 with a…
European Patient Innovation Summit: Using digital technology to improve patient care
MSP was represented at the European Patient Innovation Summit held on 4 and 5 October in Milan, Italy. Our External Relations Director Christoph Thalheim held a presentation explaining the importance of patient-relevant outcomes.
European Patient Innovation Summit: Using digital technology to improve patient care
EMSP was represented at the European Patient Innovation Summit held on 4 and 5 October in Milan, Italy. Our External…
EURORDIS: Patient survey on adverse drug reactions
EMSP is supporting a survey intiative from our partners at Rare Diseases Europe (EURODIS) aimed at reporting side-effects and receiving safety information on medicines through an app for mobile phones and tablets.
